Financial Gravity Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4
Closed -$359 1970
2023
Q4
$359 Buy
4
+2
+100% +$199 ﹤0.01% 1195
2023
Q3
$147 Sell
2
-87
-98% -$8.14K ﹤0.01% 984
2023
Q2
$47 Sell
89
-18
-17% -$1.57K ﹤0.01% 1403
2023
Q1
$181 Sell
107
-15
-12% -$1.72K 0.01% 634
2022
Q4
$35 Sell
122
-187
-61% -$21.7K ﹤0.01% 1266
2022
Q3
$175 Buy
309
+30
+11% +$2.84K 0.01% 571
2022
Q2
$156 Sell
279
-72
-21% -$6.79K ﹤0.01% 559
2022
Q1
$198 Sell
351
-3,564
-91% -$413K 0.01% 573
2021
Q4
$3.64K Buy
3,915
+3,888
+14,400% +$578K 0.08% 239
2021
Q3
$159K Buy
+27
New +$3.69K 0.07% 232
2020
Q1
Sell
-326
Closed -$139K 1123
2019
Q4
$139K Sell
326
-279
-46% -$31K 0.1% 208
2019
Q3
$58K Sell
605
-261
-30% -$29.1K 0.05% 267
2019
Q2
$100K Sell
866
-267
-24% -$31.9K 0.08% 227
2019
Q1
$128K Buy
+1,133
New +$99.2K 0.1% 181
2018
Q3
$0 Hold
2
﹤0.01% 1383
2018
Q2
$0 Sell
2
-1
-33% -$66 ﹤0.01% 1403
2018
Q1
$0 Buy
+3
New +$169 ﹤0.01% 1386

Other funds holding ASND

Financial Gravity Asset Management's ASND Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Ascendis Pharma A/S (ASND) in Q1 2024, closing a stake of 4 shares — an estimated $359 sold.

Financial Gravity Asset Management first reported a position in ASND in Q1 2018 and held it in 17 quarters. The position peaked at $159K in Q3 2021. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining Ascendis Pharma A/S position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 4 Ascendis Pharma A/S shares in Q1 2024, an estimated $359.
  • Financial Gravity Asset Management first reported a position in Ascendis Pharma A/S in Q1 2018 and held it in 17 quarters.
  • Financial Gravity Asset Management's Ascendis Pharma A/S position peaked at $159K in Q3 2021.
  • 189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.